Human bone marrow stromal cells facilitate the cord blood CD34+ cells ex vivo expansion and short-term engraftment in NOD/SCID mice.
- Author:
Xiao-Ming FEI
1
;
Yu-Jie WU
;
Zai CHANG
;
Kou-Rong MIAO
;
Xiao-Yu ZHOU
;
Qin-Qin PAN
;
Cheng-Ya WANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Antigens, CD34; Bone Marrow Cells; Cell Separation; Cells, Cultured; Cord Blood Stem Cell Transplantation; Fetal Blood; cytology; Granulocyte Colony-Stimulating Factor; pharmacology; Humans; Male; Mesenchymal Stromal Cells; Mice; Mice, Inbred NOD; Mice, SCID
- From: Chinese Journal of Hematology 2008;29(2):97-100
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the potential of human bone marrow stromal cells (MSCs) as the feeding-layer to promote ex vivo expansion of cord blood CD34+ cells and engraftment of the expanded cells in NOD/SCID mice.
METHODSHuman MSCs were routinely isolated and cultured. MSCs at passage 3 were used as feeding-layer for the expansion of cord blood CD34+ cell in the presence of thrombopoietin (TPO), flt3/flk2 ligand (FL), stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF). The engraftment potential between unexpanded and expanded cord blood cells transplanted into NOD/SCID mice was compared.
RESULTSThe total nucleated cells (TNC), CD34 cells and colony forming units (CFUs) in the MSC feeding culture were increased by 111.6-, 19.3- and 58-fold after 1 week expansion and 532.8-, 41.3- and 563.5- fold increased after 2 weeks expansion respectively as compared with that in non MSC feeding culture. In transplant experiment, the percentage of human CD45+ cells (45.3% -59.1%) in bone marrow of recipient mice transplanted with the MSC feeding expanded cells was the highest in all the groups at six weeks after transplantation.
CONCLUSIONHuman MSCs enhance CB CD34+ cells in vitro expansion and their capacity of short-term engraftment in NOD/SCID mice.